The Public Health England conducted a study in the UK and found out that two doses of the Pfizer Covid-19 vaccine proved to be 88% effective against the B.1.617.2 variant of the Covid-19 virus that was first identified in India.
Matt Hancock, the British Health and Social Care Secretary, described the findings as “groundbreaking”.
The study focused on two vaccines, the Pfizer-BioNTech and AstraZeneca, of which only the Pfizer-BioNTech vaccine is approved for use in Singapore at the moment.
The study showed that the Pfizer-BioNTech vaccine was 88% effective against the Indian variant 2 weeks after administering the 2nd dose.
The study included 1,054 people who were confirmed to have been infected with the Indian variant.
However, cases and follow-up periods have been insufficient to estimate the effectiveness of the vaccine ag sint severe outcomes from the Indian variant.
Images source: Unsplash